XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 220 filers reported holding XENON PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,458,842 | -18.1% | 88,711 | -9.5% | 0.07% | -21.8% |
| Q1 2024 | $4,220,708 | +5.2% | 98,042 | -3.6% | 0.09% | +14.5% |
| Q4 2022 | $4,010,701 | +127.9% | 101,717 | +108.7% | 0.08% | +65.2% |
| Q3 2022 | $1,760,000 | +425.4% | 48,750 | +342.3% | 0.05% | +206.7% |
| Q2 2022 | $335,000 | -60.1% | 11,023 | -59.9% | 0.02% | -59.5% |
| Q1 2022 | $840,000 | +290.7% | 27,468 | +299.4% | 0.04% | +208.3% |
| Q4 2021 | $215,000 | – | 6,878 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |